Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2013 08:00 ET | Source: Receptos, Inc.

Receptos Provides Update on Progress of Lead Product Candidate RPC1063

Successfully Completes Thorough QT Study Obtains Special Protocol Assessments (SPAs) From FDA for Phase 3 Trials in Relapsing Multiple Sclerosis SAN DIEGO, June 5, 2013 (GLOBE NEWSWIRE) --...
May 29, 2013 16:30 ET | Source: Receptos, Inc.

Receptos to Present at Jefferies 2013 Global Healthcare Conference

SAN DIEGO, May 29, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today...
May 15, 2013 16:05 ET | Source: Receptos, Inc.

Receptos to Deliver Scientific Presentations at Digestive Disease Week 2013 About the Therapeutic Role of RPC1063 in Inflammatory Bowel Disease

SAN DIEGO, May 15, 2013 (GLOBE NEWSWIRE) -- Receptos (Nasdaq:RCPT) today announced that Company personnel will deliver three scientific poster presentations about RPC1063 at the Digestive Disease Week...
May 14, 2013 21:39 ET | Source: Receptos, Inc.

Receptos Announces Completion of Initial Public Offering of Common Stock

SAN DIEGO, May 14, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today...
May 08, 2013 19:02 ET | Source: Receptos, Inc.

Receptos Announces Pricing of Initial Public Offering of Common Stock

SAN DIEGO, May 8, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today...